Citius Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cranford, NJ
SEC filing record 1 source field available
Fiscal year end
30 September
Citius Pharmaceuticals, Inc. has filed 636 SEC EDGAR filings since 23 Nov 2010

SEC filing history

Showing 51-75 of 636 matching filings.

Per page
25
Current page
3
DEFA14A File 001-38174

DEFINITIVE ADDITIONAL MATERIALS

Filing date
28 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38174

DEFINITIVE PROXY STATEMENT

Filing date
28 Apr 2025
Reporting date
09 Jun 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-38174

PRELIMINARY PROXY STATEMENT

Filing date
18 Apr 2025
Reporting date
18 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
18 Apr 2025
Reporting date
16 Apr 2025
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
03 Apr 2025
Reporting date
28 Mar 2025
Next action
Verify source filing
8-K File 001-38174

CURENT REPORT

Filing date
02 Apr 2025
Reporting date
01 Apr 2025
Next action
Verify source filing
424B5 File 333-277319

PROSPECTUS SUPPLEMENT

Filing date
02 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
10 Mar 2025
Reporting date
10 Mar 2025
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
14 Feb 2025
Reporting date
14 Feb 2025
Next action
Verify source filing
10-Q File 001-38174

QUARTERLY REPORT

Filing date
14 Feb 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
06 Feb 2025
Reporting date
06 Feb 2025
Next action
Verify source filing
10-K/A File 001-38174

AMENDMENT NO. 1 TO FORM 10-K

Filing date
27 Jan 2025
Reporting date
30 Sep 2024
Next action
Verify source filing
ARS File 001-38174

FORM ARS

Filing date
27 Jan 2025
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-38174

DEFINITIVE ADDITIONAL MATERIALS

Filing date
27 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38174

DEFINITIVE PROXY STATEMENT

Filing date
27 Jan 2025
Reporting date
10 Mar 2025
Next action
Verify source filing
PRE 14A File 001-38174

PRELIMINARY PROXY STATEMENT

Filing date
16 Jan 2025
Reporting date
10 Jan 2025
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
08 Jan 2025
Reporting date
07 Jan 2025
Next action
Verify source filing
424B5 File 333-277319

PROSPECTUS SUPPLEMENT

Filing date
08 Jan 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
07 Jan 2025
Reporting date
07 Jan 2025
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
27 Dec 2024
Reporting date
27 Dec 2024
Next action
Verify source filing
10-K File 001-38174

ANNUAL REPORT

Filing date
27 Dec 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
SC 13D/A File 005-90253

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
27 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
26 Nov 2024
Reporting date
25 Nov 2024
Next action
Verify source filing
8-K File 001-38174

CURRENT REPORT

Filing date
25 Nov 2024
Reporting date
25 Nov 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .